THROMBIN-JMI
- Product NDC
- 60793-020
- 11-digit product format
- 607930020
- Labeler code
- 60793
- Product ID
- 60793-020_3def28ab-84bb-4137-a4d8-450ef97c97cc
- Type
- PLASMA DERIVATIVE
- Nonproprietary name
- thrombin, topical (bovine)
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- BLA102865
- Marketing category
- BLA
- Marketing start
- 2026-06-08
- Substance
- THROMBIN
- Active strength
- 20000 [iU]/20mL
- Pharmacologic classes
- Blood Coagulation Factor [EPC], Blood Coagulation Factors [CS], Increased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- THROMBIN-JMI
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| THROMBIN | 20000 [iU]/20mL |
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 102865 | Thrombin-Jmi, Thrombocoll | Thrombin, Topical (Bovine) | 351(a) | Rx | 2026-09-01 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 60793-020-01 | 60793002001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (60793-020-01) / 20 mL in 1 VIAL, SINGLE-DOSE (60793-020-05) | 2026-06-08 | No | No | Current |